ScholarIQanswers from OpenAlex & ORCID
Jacob Schachter
ResearcherPublications, citations & collaboration network
Jacob Schachter is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jacob Schachter have?
ScholarIQindexed works
Jacob Schachter has 439 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jacob Schachter have?
ScholarIQcitation count
Jacob Schachter has 31,693 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jacob Schachter?
ScholarIQh-index
Jacob Schachter has an h-index of 65 in OpenAlex.
What is the i10-index of Jacob Schachter?
ScholarIQi10-index
Jacob Schachter has an i10-index of 171 in OpenAlex.
What is the ORCID of Jacob Schachter?
ScholarIQorcid
The ORCID for Jacob Schachter is on the source record.
What is the OpenAlex record for Jacob Schachter?
ScholarIQopenalex
The OpenAlex for Jacob Schachter is on the source record.
What are the most-cited papers on Jacob Schachter?
ScholarIQmost cited works
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, Rona Ortenberg, Adi Lahat, Lior H. Katz, Katerina Adler, Daniela Dick‐Necula, Stephen Raskin, Naamah Bloch, Д. Л. Ротин, Liat Anafi, Camila Avivi, Jenny Melnichenko, Yael Steinberg‐Silman, Ronac Mamtani, Hagit Harati, Nethanel Asher, Ronnie Shapira‐Frommer, Tal Brosh‐Nissimov, Yael Eshet, Shira Ben-Simon, Ziv Oren, Md Abdul Wadud Khan, Moran Amit, Nadim J. Ajami, Iris Barshack, Jacob Schachter, Jennifer A. Wargo, Omry Koren, Gal Markel, Ben Boursi
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
Michal Harel, Rona Ortenberg, Siva Karthik Varanasi, Kailash Chandra Mangalhara, Mariya Mardamshina, Ettai Markovits, Erez N. Baruch, Victoria Tripple, May Arama-Chayoth, Eyal Greenberg, Anjana Shenoy, Rüveyda Ayasun, Naama Knafo, Shihao Xu, Liat Anafi, Gali Arad, Georgina D. Barnabas, Shira Ashkenazi, Michal J. Besser, Jacob Schachter, Marcus Bosenberg, Gerald S. Shadel, Iris Barshack, Susan M. Kaech, Gal Markel, Tamar Geiger
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Michele Maio, Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Maćkiewicz, Piotr Rutkowski, Alexander Guminski, Grant R. Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Fein, Michael P. Brown, Alexander Guminski, Andrew Haydon, Adnan Khattak, Catriona M. McNeil, Phillip Parente, Jeremy Power, Rachel Roberts‐Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas Berger, Ahmad Awada, Nathalie Blockx, Véronique Buyse, Jeroen Mebis, Fábio Franke, Sérgio Jobim Azevedo, Nicolas Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa M. Petrella, Kerry J. Savage, Ralph Wong, Ralph Wong, Nina Dabelić, Stjepko Pleština, Željko Vojnović, Petr Arenberger, Ivo Kocák, Ivana Krajsová, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchová, Kadri Putnik, Brigitte Dréno, Caroline Dutriaux, Jean‐Jacques Grob, P. Joly, J.‐P. Lacour, Nicolás Meyer, Laurent Mortier, L. Thomas, Michael Fluck, Thilo Gambichler, Jessica C. Hassel, Axel Hauschild, Dirk Schadendorf, Paul Donnellan, John McCaffrey, Derek G. Power, Samuel Ariad, Gil Bar‐Sela, Daniel Hendler, Ilan G. Ron, Jacob Schachter, Paolo Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion‐Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Michele Maio, Michele Maio, Mario Mandalà, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Andrzej Mackiewicz, Piotr Rutkowski, P. Ferreira, Lev Demidov, Georgy Gafton, Yulia Makarova, Zoran Andrić, Nada Babović, Darjana Jovanovic